Recent results from NIF showing accelerating increases in gain suggest laser ICF is the most derisked path to commercialisation. A panel of  laser fusion innovators, their investors and suppliers explore this thesis.

• To what extent do the results from LLNL derisk private sector ICF companies?
• There are several feasible paths to the commercialisation of ICF, what are the cost, risk or other benefits of different approaches? 
• Japan’s national strategy commits to supporting laser ICF; what role can Japan and its innovators, partners or suppliers play in ICF’s advance?